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Abstract
Background: The burden of chronic pain is a major challenge, impacting the quality of life of patients. Intensive
programmes of mindfulness-based therapy can help patients to cope with chronic pain but can be time consuming and
require a trained specialist to implement. The self-management model of care is now integral to the care of patients
with chronic pain; home-based interventions can be very acceptable, making a compelling argument for investigating
brief, self-management interventions. The aim of this study is two-fold: to assess the immediate effects of a brief self-help
mindfulness intervention for coping with chronic pain and to assess the feasibility of conducting a definitive randomized
controlled trial to determine the effectiveness of such an intervention.
Methods/Design: A randomized controlled pilot study will be conducted to evaluate a brief mindfulness intervention
for those with chronic pain. Ninety chronic pain patients who attend hospital outpatient clinics will be recruited and
allocated randomly to either the control or treatment group on a 1:1 basis using the computer-generated list of random
numbers. The treatment group receives mindfulness audios and the control group receives audios of readings from a
non-fiction book, all of which are 15 minutes in length. Immediate effects of the intervention are assessed with brief
psychological measures immediately before and after audio use. Mindfulness, mood, health-related quality of life, pain
catastrophizing and experience of the intervention are assessed with standardized measures, brief ratings and brief
telephone follow-ups, at baseline and after one week and one month. Feasibility is assessed by estimation of effect
sizes for outcomes, patient adherence and experience, and appraisal of resource allocation in provision of the
intervention.
Discussion: This trial will assess whether a brief mindfulness-based intervention is effective for immediately reducing
perceived distress and pain with the side effect of increasing relaxation in chronic pain patients and will determine the
feasibility of conducting a definitive randomized controlled trial. Patient recruitment began in January 2015 and is due
to be completed in June 2016.
Trial registration: ISRCTN61538090 Registered 20 April 2015
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Background
The burden of chronic pain is a major challenge within
healthcare, as approximately 14 million people in England
alone currently live with chronic pain [1]. Chronic pain has
a negative impact on quality of life [2] and results in high
levels of disability [3], with 41 % of patients attending pain
clinics reporting being unable to work [4]. Furthermore,
high comorbidity rates of depression and anxiety [5] are
common, with the 2008 Chief Medical Report stating that
16 % of sufferers report that their chronic pain is so bad
that they sometimes want to die [6]. In the UK, the cost for
back pain alone has been estimated at £12 billion per
annum, which may be partially explained by the fact that,
as is reported [6], 25 % of pain sufferers lose their jobs.
Psychological therapies, most commonly in the form of
cognitive behavioural therapies [7, 8], have been shown to
play an important role in helping patients cope with
chronic pain [9, 10]. More recently, mindfulness-based ap-
proaches have emerged [11], involving training patients to
engage in self-regulation of attention through increasing
awareness of, and accepting, present thoughts, feelings
and physical sensations [12].
Among those with chronic pain, mindfulness interven-
tions have been shown to reduce anxiety, depression and
distress, and to enhance quality of life [13]. Recent UK
National Health Service (NHS) guidelines include a recom-
mendation for mindfulness meditation in treating depres-
sion [14]. There is also evidence that regular mindfulness
meditation modulates neural mechanisms [15, 16], espe-
cially those related to pain, as well as benefits for inflam-
matory systems [17].
While this research is promising, a major barrier with
the implementation of current mindfulness interventions is
the amount of time they require and the necessity of a
trained specialist to oversee them [18]. Mindfulness pro-
grammes typically involve weekly group-based sessions
over 8 weeks and many chronic pain patients do not have
the resources, physically or mentally, to engage with such
an intensive programme [19, 20]. Self-help type interven-
tions, which offer more autonomy, are likely to be more
adaptable for many such patients and the self-management
model of care is now an integral part of the NHS [21]. This
model has led to the development of a breadth of interven-
tions with some evidence for efficacy ranging from web-
based interventions to brief interventions that patients can
readily use as part of a self-care programme.
One type of brief intervention that fits this profile is a
short mindfulness-based body or breathing scan. These
scans are a key component of mindfulness meditation
practice; they involve being directed to focus attention
on the present moment through observing the breath
and bodily sensations, while becoming aware of, and
accepting without judgement, any thoughts and feelings
which arise. The traditional mindfulness-based stress
reduction intervention includes a body scan [22], lasting
anything from 5 to 45 minutes.
There has been little research testing brief mindfulness
interventions in either clinical or non-clinical populations.
Investigations with healthy populations with a brief mind-
fulness intervention have been successful in demonstrat-
ing a reduction in some aspects of the pain experience,
such as distress and sensitivity, during experimental pain
studies [23, 24]. An audio-guided 10 minute mindfulness
body scan has also been shown to reduce tobacco cravings
among abstinent smokers [25, 26]. In a chronic pain
population, encouraging effects were found, with an audio
recording of a 10-minute body scan reducing reports of
distress immediately after listening to the audio in a clin-
ical setting [27]. The intervention evaluated in the current
study is a refinement of the intervention used in the latter.
Aims and objectives
The aim of this paper is to describe the protocol for a pilot
randomized controlled trial designed with two primary
objectives: assessment of the immediate effects of a brief
mindfulness-based intervention on patients with chronic
pain and evaluation of the intervention to assess the feasi-
bility of conducting a definitive randomized controlled
trial. As regards to the immediate effects of the interven-
tion, it is hypothesized that the intervention will result in




This is a single centre, parallel group, randomized con-
trolled pilot study (see Fig. 1 for a flowchart), designed
to assess the immediate effects of a mindfulness-based
intervention, as well as the feasibility of conducting a de-
finitive randomized controlled trial.
Participants and setting
Patients are being recruited from three outpatient NHS
physiotherapy/pain clinics at St. George's University
Hospitals NHS Foundation Trust. All patients are ini-
tially screened by the appropriate clinician (i.e. physio-
therapist or pain consultant). Those who meet the
inclusion criteria are given a patient information sheet
by the clinician and are asked whether they consent to
have their contact details passed to a researcher who
will call them to discuss whether they wish to join the
study or if they would like to meet with the researcher
in person to discuss the study.
Patients are eligible if they meet the following criteria:
(1) over 18 years of age; (2) living with chronic pain (i.e.
those who live with a diagnosis of chronic pain or those
who have had pain for more than three months after the
time healing should have occurred [19]); and (3) able to
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hear audio recordings or have their own equipment to
enable them to do so.
Patients are excluded if they are (1) considered by the
clinician to be too unwell to participate or (2) unable to
speak or read English sufficiently to understand and
complete the self-administered questionnaires.
Sample size
It is recommended that pilot/feasibility studies ideally re-
cruit a total of at least 50 participants [20], although in
practice many studies recruit 50–100 participants. We aim
to recruit 90 participants (45 in each treatment arm). Then,
allowing for 10 participants withdrawing (estimate based on
a previous mindfulness study with the same population
[27]), we aim to have around 80 participants with data
through to the final one month follow-up. Moreover, based
on a finding from a previous similar study [27], we used a
Wilcoxon signed-rank test (G-Power software) to calculate
that a total sample size of at least 50 participants would be
required to detect a significant difference of 1.2 (SD = 2) on
the perceived distress scale, between the two groups (imme-
diately) after the intervention. This was with 80 % power at
the 5 % significance level.
Randomization
An independent statistician generates a randomization list
using the online resource ‘Research Randomizer’. This list
is used by researchers to allocate volunteers to either
the control or treatment group on a 1:1 basis. Pa-
tients are allocated their number in ascending order
based on their order of enrolment. Allocation is con-
cealed from the participant and researcher until all
baseline assessments have been completed. Due to
limited resources, the same researcher delivers the
intervention and administers the research measures,
and therefore treatment allocation cannot be con-
cealed from the researcher. Thus, neither participants
nor researchers are blinded to treatment allocation
during intervention delivery or during outcome as-
sessment. An independent statistician, who is blinded
to the treatment allocation, will complete the initial
analysis for the main outcomes.
Interventions
To improve the reporting of the interventions, the Tem-
plate for Intervention Description and Replication [28]
and the SPIRIT (Standard Protocol Items: Recommenda-
tions for Interventional Trials) checklist and figure [29]
have been used to guide the description of the interven-
tions. The SPIRIT checklist itself is attached in Add-
itional file 1, presenting items addressed in the reporting
of the protocol overall and the SPIRIT figure is attached
in Additional file 2, summarizing a schedule of enrol-
ment, interventions, and assessments.
Fig. 1 Flow diagram of the feasibility study design assessing the effects of a brief mindfulness intervention for those living with chronic pain
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Treatment group: brief self-management mindfulness-based
audios
Patients in the treatment group are given an audio re-
cording of a 15-minute mindfulness body scan on an
MP3 player (with earphones) or are offered the option of
having the audio downloaded directly to a personal de-
vice of their choice, such as a smart phone or iPad.
The choice of the body scan meditation for the audio
was based on successful traditional mindfulness-based
stress reduction interventions, which routinely include a
body scan meditation as the introductory exercise. In a
clinical setting with a chronic pain population, a brief
(10 minute) version of the body scan was found to re-
duce reports of distress, immediately after listening to
the audio [27].
The body scan used in this study is an extended version
of a 10-minute body scan used in a qualitative study (to be
published elsewhere) investigating the acceptability of the
intervention to patients. It is based on a transcript from
Breathworks [30], an established mindfulness organisation
specialising in supporting those with chronic pain. As part
of the prior qualitative study, and in response to feedback
from patients, the intervention was extended from 10 to
15 minutes so that it would feel less rushed.
The audio recording directs the listener to systematic-
ally ‘scan’ their body with their attention, starting with
the toes and finishing with the crown of the head.
Throughout this process, the listener is also encouraged
to be aware of their breathing and to accept all thoughts
and feelings, whether positive or negative, without trying
to alter them in any way. This intervention is adminis-
tered face-to-face for the initial use by a researcher in a
clinical setting (i.e. physiotherapy/medical side room or
cubicle) and telephone follow-up at one week and
one month is conducted by the same researcher. Use of
the audio at least three further times during the first
week is requested and, after that, use is encouraged but
no set number of times is prescribed for the following
three weeks. Following administration of the intervention,
a study packet, including information and instructions for
use of the audios along with brief information regarding
mindfulness (i.e. frequently asked questions) and question-
naires to be filled out at home, is given to the patient. The
inclusion of an information sheet was developed in re-
sponse to patient feedback in the previous qualitative study.
An audio of a breathing meditation and a moving
meditation are given to the treatment group as well, but
use is not recommended until after one week. The
breathing meditation is an exercise where breath is used
as an object of concentration and the listener is asked to
focus on the sensations of breathing (e.g. the feeling of
the chest rising and falling). The moving meditation is
focused on gentle exercises (e.g. small wrist twists or
arm movements), which can be done sitting or standing
and the listener is guided to pay attention to bodily sen-
sations after making each movement. Both are based on
transcripts from Breathworks.
Control group: relaxation/distraction audios
Patients in the control group are given eight, 15-minute
audio recordings of sequential readings from “The English
Village: History and Traditions” [31], which is a non-
fiction book considered to be neutral in nature. The read-
ings start from the beginning of the book and the hope is
that enough interest is generated as the story progresses,
so as to encourage patients to listen to a total of four ses-
sions in the first week as easily as those in the treatment
group. In total, eight sessions were recorded with the
intention that four recordings would be used in the first
week and that the remaining four could be used in the fol-
lowing three weeks. As with the treatment group, patients
are given an MP3 player (with earphones) or the option of
having the audios downloaded directly to a personal de-
vice. For the first session in clinic, the first of these se-
quential readings, which is also the first section of the
book, is presented. Non-fiction material, similar in style
and content, has been used in a previous study examining
the acute effects of mindfulness among those with chronic
pain, where it has been found to be an acceptable inter-
vention [27]. Recordings were made using the same narra-
tor as the intervention, and are read at a similar pace and
with comparable pauses.
As with the treatment group, use of the audios is re-
quested at least three further times during the first week.
After that, continuing use is encouraged, with no set
prescription for the following three weeks. Following ad-
ministration of the control intervention, the study packet,
including information and instructions for use of the audios
(minus the mindfulness frequently asked questions that are
included for the treatment group) and questionnaires to be
filled out at home, is given to the patient.
Procedure in clinic
Patients who meet the inclusion criteria are approached
by the research team and given a patient information
sheet regarding the study. Patients are given as much
time as they want to consider whether they want to par-
ticipate and written consent is obtained from all patients
who agree to do so. Delivery of the intervention is stan-
dardized, with a researcher checklist (i.e. written man-
ual) including a step-by-step script developed to address
fidelity issues. This script and checklist are used during
recruitment and researchers observed each other admin-
istering the intervention to at least one patient each so
as to standardize procedures.
As detailed previously, an initial face-to-face visit is con-
ducted in a private room or cubicle at St George’s Hospital
or St John’s Therapy Centre. Patients are randomized to
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either the control or treatment group and asked to
complete baseline measures, including brief psycho-
logical measures, and to listen to the relevant audio
once in clinic with the researcher. After listening to the
audio, patients are asked to complete the brief psycho-
logical measures again. Before leaving, patients are ad-
vised to consider barriers and solutions to use of the
audio in their own environment and are given a study
packet to take home. They are instructed to use the au-
dios as a self-management tool and to try the audio
during particularly painful times if possible. The contents
of the study packet containing follow-up questionnaires
(i.e. Study Diaries 1–3), self-addressed prepaid return en-
velopes and brief instructions, are then reviewed with the
patient in case there are any queries. If the audios are not
directly downloaded to a personal device, patients are
allowed to keep the MP3 players if they want after they
finish, as they are a minimal cost. The offer of the MP3
player is not mentioned in the patient information
sheet, and therefore is not considered as an incentive to
recruitment.
Measures and schedule of assessment
Baseline data collection
Patients are asked to provide demographic details includ-
ing age, marital status, occupation, education and ethnic
group along with five pain-related questions, namely:
“What is your clinical diagnosis?”, “How long have you
been living with your pain?”, “Are you currently taking any
medication for your pain and if so, which one/s?”, “Over
the last week, how confident have you been in managing
your pain” (1 = not at all confident to 7 = extremely
confident), and “During the past week, how much has your
work or other regular daily activities been limited as a
result of your pain symptoms?” (1 = not at all to 5 = ex-
tremely). They then complete a measure of mood (Hospital
Anxiety and Depression Scale; HADS [32]), a mindfulness
questionnaire (Cognitive and Affective Mindfulness Scale-
Revised; CAMS-R [33]), a pain-specific questionnaire (Brief
Pain Inventory; BPI [34]), a pain catastrophizing question-
naire (Pain Catastrophizing Scale; PCS [35]), and a health-
related quality of life (HRQoL) questionnaire (EuroQol – 5
Dimension – 5 Levels; EQ-5D-5 L [36]). Immediately
before and after the initial use of the audio in clinic, pa-
tients are asked to complete three questions regarding their
level of distraction, pain severity and pain distress (1 = not
at all to 5 = extremely). Full details of the measures are
given below.
Measures to be completed during the first week
Study Diary 1 includes a self-monitoring table detailing
date, time and position of use (e.g. sitting or lying) of the
audios and a repeat of the baseline brief measures of
level of distraction, pain severity and pain distress
immediately before and after the last session of listening
to the audio during the first week.
Measures to be completed after one week
Study Diary 2 includes a brief questionnaire where pa-
tients are asked: “How useful did you find the audio guide
for helping you to relax?” (1 = not at all to 5 = extremely
useful), and “Would you recommend this audio guide to
others to help manage their chronic pain?” (1 = definitely
would not recommend to 5 = definitely would recommend
it). To assess level of experience of activities related to
mindfulness, the question: “Have you had experience of
yoga, tai-chi or any type of meditation?” (1 = no experi-
ence of these activities to 7 = I currently practice these ac-
tivities at least once a week) is included. These questions
are followed by a repeat of the measure of mindfulness
that was completed at baseline so as to detect any early
changes in mindfulness present after one week.
Measures to be completed during and after one month
Study Diary 3 includes another self-monitoring table
where patients can continue to detail date, time and
position of use of the audios during the three weeks
prior to the final 1 month follow-up. At 1 month, items
regarding pain self-efficacy and physical function are
repeated in addition to the measures of mood, pain cat-
astrophizing, mindfulness, and HRQoL that were ad-
ministered at baseline. While one week is likely too
brief for patients to make (meaningful) changes in
physical and/or psychological function, assessment after
the completion of the intervention (one month) will
better allow for the detection of changes in function
where they have occurred.
A brief assessment of whether they have continued lis-
tening to the audio (and if so, how often), a discussion of
the main barriers to and facilitators of use, and their view
on the beneficiality of an online support group forum,
texting support and more face time, is conducted with a
brief (around 5 minutes) open-ended telephone interview.
A schedule of assessment for all measures included is pre-
sented in Table 1 below.
Intervention behaviour change techniques at one week
At one week, the researcher follows up by telephone and
encourages continued use of the intervention, identifies
perceived barriers and benefits of use and sets goals with
the patient by recommending continued use of the inter-
vention at least three times a week. Self-monitoring by
diary is also encouraged. These behaviour change tech-
niques come under the labels “Goal setting” or “Action
planning”, “Self-monitoring of behaviour” and “Problem
solving” as per the Behavior Change Techniques Tax-
onomy (v1) [37], which is the established standardized
taxonomy for behaviour change techniques.
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Debrief at one month
Patients are followed up after one month by telephone
for a study debrief. Patients are debriefed regarding the
full nature of the study and, if they are part of the con-
trol group, they are offered to have the intervention au-
dios sent to them in case they wish to try them.
Resources that are readily available to the public are rec-
ommended at this time if patients wish to further ex-
plore mindfulness. Patients are reminded to complete
and post back the questionnaires.
Measures
Hospital Anxiety and Depression Scale
The HADS is an easily-administered screening question-
naire designed by Zigmond and Snaith [32], which has
been widely used as a tool to assess the severity of de-
pression and anxiety. Patients are asked to respond to 14
items, seven measuring anxiety and seven measuring de-
pression. The respondent must choose one of four re-
sponses for each item according to how they have felt
over the previous week. A score of 0–21 is calculated for
each disorder with total scores between 11–21 indicating
abnormal levels of anxiety/depression [38]. The HADS
has also been routinely used for research within chronic
pain populations [39–42].
Cognitive and Affective Mindfulness Scale–Revised
The CAMS-R [33] is a revised version of the Cognitive
and Affective Mindfulness Scale [43], which is an 18-
item measure designed to capture mindfulness as a gen-
eral daily experience. The CAMS-R is a 10-item scale
which uses everyday language appropriate for those with
little meditation experience and has been compared with
two other existing mindfulness measures, the Mindful-
ness Attention Awareness Scale [44] and The Freiburg
Mindfulness Inventory [45], where it was found to be
positively correlated (r = 0.51, P < 0.001 and r = 0.66,
P < 0.001, respectively) [46, 47], with an acceptable in-
ternal consistency (a = 0.76) [33], which was a weakness of
the original scale. The CAMS-R is unique in that it is re-
lated to psychological distress, which is highly relevant to
the current study and chronic pain population.
EuroQuol – 5 Dimensions – 5 Levels
The EQ-5D-5 L [36] is the most recently developed ver-
sion of the EQ-5 Dimensions [48, 49], which is a standar-
dised measure of health status that has good construct
validity and responsiveness among people with chronic
pain [50]. Developed by the EuroQol group, it is sup-
ported by the National Institute for Clinical Excellence
(NICE) for measuring change in health-related quality of
life with various patient groups [51], has been validated
within numerous patient groups including the chronic
pain population, and has been shown to be a sensitive tool
with internal consistency and reliability [52–55].
The Brief Pain Inventory
The BPI [34] is an easy to use tool for the assessment
of pain in both clinical and research settings and uses
simple numeric rating scales from 0 to 10 (with 0 = no
pain to 10 = pain as bad as you can imagine). The BPI
has been used internationally [34, 56, 57] to measure
severity and interference of pain in patients who live
with a range of chronic pain presentations.
Pain Catastrophizing Scale
The PCS [35] is a 13-item scale consisting of statements
regarding the thoughts and feelings that patients report
when they experience pain scored from 0 (not at all) to
4 (all the time). Total PCS scores range from 0 to 52
Table 1 Schedule of data and measurement collection
Measure Baseline During week At 1 week During month At 1 month
Background and pain-related questionnaire X
Pain self-efficacy item X X
Pain and physical function item X X
Mood questionnaire (HADS) X
Mindfulness questionnaire (CAMS-R) X X X
Pain-specific questionnaire (BPI) X
Pain catastrophizing questionnaire (PCS) X X
Health-related quality of life questionnaire (EQ-5D-5L) X X
Brief psychological measures (two times, before and after intervention) X X
Experience of audio items X
Previous experience X
Self-monitoring table X X
HADS, Hospital Anxiety and Depression Scale; CAMS-R, Cognitive and Affective Mindfulness Scale Revised; BPI, Brief Pain Inventory; PCS, Pain Catastrophizing Scale;
EQ-5D-5 L, EuroQuol – 5 Dimensions – 5 Levels
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points and higher scores indicating higher levels of pain
catastrophizing. The PCS consists of three subscales,
which are magnification, rumination, and helplessness.
The scale was developed to be used within both clinical
and non-clinical populations and was originally an elab-
oration on the Coping strategies Questionnaire [58]. The
PSC has been shown to have reliability and validity in
both pain populations and healthy adult populations
with a high internal consistency [59].
Brief measures to be completed before and after audio in
clinic and the last session during the first week at home
Three brief, single-item measures are used to assess
level of distractedness, pain severity and pain distress.
Patients are asked to rate “How distracted do you feel
right now?” (devised specifically for this study), “How se-
vere are your pain related symptoms right now?”, and
“How distressing are your pain related symptoms right
now?”, all on a scale from 1 (not at all) to 7 (extremely so).
Statistical analysis
We will present the baseline characteristics according to
the two study groups. For the analysis assessing the im-
mediate effects of the intervention, we will assess the ef-
fect of the body scan versus the control intervention on
ratings for the brief psychological measures administered
immediately before and after the interventions. This ana-
lysis will be conducted for the ‘before’ and ‘after’ ratings
in the clinic and also for those conducted in the partici-
pant’s own environment. First, we will compute change
scores by subtracting post-intervention scores from pre-
intervention scores. As it is a pilot study with a small sam-
ple size, initially we will assess the effect of the treatment
groups on outcomes (i.e. change scores) using t tests or
Mann–Whitney tests. We will then conduct multiple
linear regressions with the change scores as the dependent
variables and treatment groups as the independent vari-
able. Statistical significance will be assessed with the
likelihood-ratio test, with the estimate of effect given as
mean difference of change scores and 95 % confidence
interval. As a secondary analysis we will adjust for age,
sex and baseline BPI score, as potentially important
prognostic baseline factors. We will also inspect the
baseline characteristics, for the two groups, to assess
whether there are any other potential confounders that
need to be controlled for.
Next, we will assess the effect of the study groups on
outcomes recorded at baseline and one month. All par-
ticipants with data at both time points will be included
in the analysis. It is unlikely that the study will be suffi-
ciently powered to detect significant differences between
the groups but we will carry out analyses in order to in-
form parameters for a definitive trial. We will compute
change scores between baseline and one month for the
HADS, EQ-5D-5 L, PCS and the CAMS-R, and we will
conduct multiple regressions, with adjustments as above.
We will also repeat this procedure for the CAMS-R at
baseline and one week.
Before conducting any of the regression analyses, we
will assess the distribution of residuals of the dependent
variable(s). We will use the bootstrap method if the distri-
bution of the residuals of the dependent variable in any re-
gression model is not normal. In the case of missing data
at one week or one month, we will conduct a sensitivity
analysis, in which we will use multiple imputation to im-
pute values for those with missing data for any variables.
We will use t tests or Mann–Whitney tests to compare
scores for ratings of ‘usefulness’ and for whether partici-
pants would recommend the intervention. All data will
be analysed using SPSS V19, with the level of signifi-
cance set at P < 0.05.
Discussion
As consistent, accessible chronic pain management is a
huge challenge across the NHS, testing the feasibility of
a brief, accessible intervention that could be easily intro-
duced into current NHS practice addresses a key issue
in the area of chronic pain research. The usefulness and
logistics of implementing a brief self-management inter-
vention into the existing NHS environment is assessed
with this study, which has been designed to investigate
both acute effects and feasibility. The acute effects will
provide an indication of how effective the intervention is
and the feasibility assessment will inform the potential
likelihood of conducting a definitive randomized con-
trolled trial investigating effectiveness and cost effective-
ness of a brief self-help mindfulness tool. Eligibility,
recruitment and retention rates will be audited along
with resources used in provision of the intervention, in-
cluding costs of the MP3 players, telephone calls, text
messages and staff time needed for intervention delivery.
This information alongside patients’ adherence to the
treatment regimen, experiences of the intervention, and
its acceptability and usefulness will allow for a rigorous
and well-designed definitive randomized controlled trial
to be conducted if findings are positive.
One of the main limitations of the study is that, for
pragmatic reasons, the researcher assessing outcomes is
not blinded to the participants’ intervention status. We
have attempted to minimize researcher bias by, as far as
possible, assessing patient outcomes with validated self-
report instruments. Additionally, to further minimize bias,
the statistician analysing the data will be blind to the treat-
ment allocation of the participants. It is hoped that a
definitive trial would take measures to ensure that the re-
searchers assessing outcomes are blinded to the allocation
of participants. Another noteworthy limitation is our in-
ability to monitor patient adherence to the intervention
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when listening to the audio at home. It is anticipated that,
in a full trial, ecological momentary assessment would be
used to monitor adherence, including having an audio
player that records the level of usage.
Current study status
Patient recruitment began in January 2015 and is due to
be completed in July 2016.
Additional files
Additional file 1: SPIRIT checklist. (DOC 744 kb)
Additional file 2: SPIRIT figure. (DOC 52 kb)
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